Globus Medical (GMED) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall St set for higher open as AI stocks rise, oil slides
- Streamflation drives 39% of Americans to cancel streaming in 6 months
Globus Medical Reports First Quarter 2017 Results
May 3, 2017 4:15 PM EDTAUDUBON, Pa., May 03, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2017.
Worldwide sales were $155.8 million, an increase of 11.9% as reported, or 12.1% in constant currencyFirst quarter net income was $28.7 million, or 18.4% of salesDiluted earnings per share (EPS) were $0.30Non-GAAP diluted EPS were $0.32Non-GAAP adjusted EBITDA was 37.1% of salesDavid Paul, Chairman and CEO said, Our worldwide sales for the first quarter were $155.8 million, an increase of 11.9%... More
